| Characteristic | Production in million euros |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
Source
Release date
June 2026
More information
Region
Europe
Survey time period
2024
Supplementary notes
EFPIA: European Federation of Pharmaceutical Industries and Associations
All data based on SITC 54
Cyprus, Estonia, Hungary, Iceland, Malta, Netherlands, Romania, Serbia, Slovenia, Spain, U.K.: 2023 data; Turkey: 2020 data; Cyprus, Estonia, Iceland, Malta, Netherlands, Romania, Serbia: Eurostat NACE Rev. 2 Croatia, Denmark, France, Ireland, Italy, Norway, Portugal, Slovakia, Slovenia, Spain, Sweden, Switzerland: estimate Bulgaria, Croatia, Hungary, Ireland, Norway, Portugal: veterinary products excluded
Citation formats
